-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2018, the National Institute of Aging and the Alzheimer's Association (NIA-AA) research framework proposed the AT(N) system as the biological definition of Alzheimer's (AD), based on amyloid (A) The pathological process of phosphorylated tau (T) and neurodegeneration (N)
Given the invasive nature of obtaining CSF and the time and cost associated with neuroimaging, identifying biomarkers that are easier to obtain is an important goal
Blood biomarkers for AD and other dementias are very suitable for screening or diagnosis in the population , as well as for continuous evaluation to track disease progression
Screening diagnosis
This is especially important for establishing the reference range
It is important to understand whether levels vary with age and gender, or whether conditions such as chronic kidney disease (CKD) that can affect protein clearance should be considered
They analyzed the plasma markers (Aβ42, Aβ40, NfL, T-tau, Aβ42/40 ratio of 996 Mayo Clinic Aging Study (MCSA) participants aged 51 to 95 years on the Quanterix Simoa HD-1 analyzer ) To take a measurement
They found that in the cognitively impaired (CU), all plasma markers were age-related
For example, a higher Charlson comorbidity index and chronic kidney disease are associated with higher levels of all biomarkers
The important significance of this study is to illustrate; multiple variables affect the plasma biomarkers of amyloid pathology and neurodegeneration in the general population
Several variables influence the plasma biomarkers of amyloid pathology and neurodegeneration in CU in the general population
Leave a message here